Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Growth-associated protein 43 (GAP-43) is a neuron-specific, membrane-associated phosphoprotein crucial for axonal outgrowth, synaptic plasticity, and neural regeneration. Highly expressed during development and after neuronal injury, GAP-43 is associated with the presynaptic membrane, influencing actin cytoskeleton remodeling, axon guidance, dendrite formation, and memory function. It serves as a substrate for protein kinase C (PKC) and binds calmodulin and phospholipids, functioning as an adaptor protein at nerve terminals. Changes in GAP-43 expression or function have been linked to neurodevelopmental disorders, epilepsy, and neurodegenerative diseases such as Alzheimer’s, where it is also being explored as a biomarker for disease progression and synaptic integrity. GAP-43 mutations or dysregulation result in defective neural connectivity and severe developmental phenotypes.
In preclinical models, DHF increases GAP-43 expression, believed to improve neuronal survival and reduce pathology by mimicking BDNF signaling. Drugs targeting PKC can indirectly modulate GAP-43 function through its phosphorylation in neurons.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Growth-associated protein 43 (GAP-43).